Volatile Markets Delay the Great IPO Rebound Again Surging volatility grounded the IPO party before it took off, as markets grappled with a tech sell-off, more tariff turmoil, private credit woes, and war in the Middle East in the first quarter of 2026. After ...read more
Thirteen IPOs raised a combined $4.4 billion in February, joined by two direct listings. Deal flow started off strong but stumbled mid-month as concerns around AI disruption sparked a sell-off in tech stocks and recent listings, and heightened volatility led to ...read more
Eikon Therapeutics, a Phase 2 biotech developing in-licensed therapies for immuno-responsive cancers, raised $381 million in an upsized IPO by offering 21.2 million shares at $18, the high end of the range of $16 to $18. The company originally planned to offer...read more
Updated Monday, 2/2. Eight IPOs raising at least $100 million are currently scheduled for the week ahead. If all eight deals price, it would be the busiest week for sizable offerings since 2021. Only one other week over the past four years has produced seven...read more
Updated: Renaissance Capital's 1Q 2026 US IPO Market Review
Volatile Markets Delay the Great IPO Rebound Again Surging volatility grounded the IPO party before it took off, as markets grappled with a tech sell-off, more tariff turmoil, private credit woes, and war in the Middle East in the first quarter of 2026. After ...read more
Renaissance Capital's February IPO Market Update
Thirteen IPOs raised a combined $4.4 billion in February, joined by two direct listings. Deal flow started off strong but stumbled mid-month as concerns around AI disruption sparked a sell-off in tech stocks and recent listings, and heightened volatility led to ...read more
Immuno-responsive cancer biotech Eikon Therapeutics prices upsized IPO at $18 high end
Eikon Therapeutics, a Phase 2 biotech developing in-licensed therapies for immuno-responsive cancers, raised $381 million in an upsized IPO by offering 21.2 million shares at $18, the high end of the range of $16 to $18. The company originally planned to offer...read more
US IPO Week Ahead: At least 8 sizable IPOs teed up in one of the busiest weeks in four years
Updated Monday, 2/2. Eight IPOs raising at least $100 million are currently scheduled for the week ahead. If all eight deals price, it would be the busiest week for sizable offerings since 2021. Only one other week over the past four years has produced seven...read more